Share Facebook Twitter LinkedIn Pinterest Email FDA accepts Adaptimmune BLA for afami-cel, decision expected by Aug. 4
Key deals this week: Chart Industries, Northwind Midstream, AbbVie, Palo Alto Networks and moreAugust 2, 2025
Trending stocks this week: Wall Street stumbles, Big Tech shines, and Figma steals the showAugust 2, 2025